An early-stage venture firm requested a high-level commercial due diligence of a potential investment in the digital pathology space
DeciBio presented a deliverable detailing the digital pathology landscape, the company's ability to compete in the space, and potential go-to-market plans and considerations.
U.S. and Europe
Pharma & Biotech
Novel Technology Commercialization